Cutler Group LP Mersana Therapeutics, Inc. Call Options Transaction History

Cutler Group LP

6 transactions

Quarter	Operation	Price Per call	calls change	calls Held
Q2 2023 Jul 18, 2023	BUY	$3.08 - $9.55 $92,400 - $286,500	30,000 New	30,000 $5,000
Q1 2022 Apr 14, 2022	SELL	$3.74 - $6.63 $374 - $663	-100 Reduced 50.0%	100 $0
Q1 2021 Apr 26, 2021	SELL	$15.31 - $26.52 $313,855 - $543,660	-20,500 Reduced 99.03%	200 $0
Q4 2020 Jan 21, 2021	BUY	$16.84 - $27.59 $341,852 - $560,077	20,300 Added 5075.0%	20,700 $26,000
Q3 2020 Oct 27, 2020	SELL	$16.2 - $25.7 $168,480 - $267,280	-10,400 Reduced 96.3%	400 $2,000
Q2 2020 Jul 22, 2020	BUY	$5.24 - $23.4 $56,592 - $252,719	10,800 New	10,800 $42,000

121

116M

233K

457K

Ticker MRSN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 97,169,296
Market Cap $216M
Description
Mersana Therapeutics, Inc., a clinical stage biopharmaceutical company, develops antibody drug conjugates (ADC) for cancer patients with unmet need. It develops XMT-1592, a Dolasynthen ADC targeting NaPi2b-expressing tumor cells, which is in phase I clinical trial for the treatment of ovarian cancer and NSCLC adenocarcinoma. The company also dev...

Get notified when there are updates to the investment portfolio of Cutler Group LP, based on Form 13F filings with the SEC.

Stay updated on Cutler Group LP with notifications on news.